Favipiravir

Favipiravir Provides Multiple Benefits In Coronavirus Treatment, Says Glenmark Pharmaceuticals

Drug firm Glenmark Pharmaceuticals on Monday said as per recently published data the oral antiviral medication Favipiravir was found to provide multiple benefits in COVID-19 treatment including faster time to…

View Post

Spotlight

Health Ministry Issues FAQs On Better Clinical Management Of COVID Patients In ICUs

As part of the COVID management and response policy, there has been a sharp focus of the Central Government on not only containing the COVID related fatality, but to reduce…

View Post

Latest News

Covid-19: Converge Biotech Launches Generic Favipiravir Tablet ‘VERGIFLU’ In India

Hyderabad-based healthcare company Converge Biotech, has announced the launch of generic Favipiravir tablet in India. It will be marketed under the brand name ‘VERGIFLU’ and is indicated for use in…

View Post

Latest News

Biophore India Gets DCGI Nod To Manufacture COVID Drug Favipiravir

Hyderabad-based Biophore India Pharmaceuticals has received license from the Drug Controller General of India (DCGI) to manufacture Favipiravir. Favipiravir is used in the finished formulation to treat mild to moderate…

View Post

Latest News

COVID-19: Antiviral Drug Favipiravir Now Cheaper By 27 Per Cent

Drug firm Glenmark Pharmaceuticals has cut the price of its antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19, by 27…

View Post

Spotlight

Delhi’s Lok Nayak Hospital Discontinues Use Of Favipiravir For COVID-19 Treatment

Amid the ongoing debate over benefits and side-effects of using the antiviral medication Favipiravir, Delhi government-run Lok Nayak Hospital – the national capital’s first COVID-19 only facility – has decided…

View Post

Spotlight

Lack Of Transparency In Subject Expert Committee Formed For Approval Of COVID-19 Drugs: AIDIAN

All India Drug Action Network (AIDAN) has written a letter to Drugs Controller of India and the Central Drugs Standard Control Organisation (CDSCO) highlighting the lack of transparency about the…

View Post

Menu

Favipiravir

Favipiravir Provides Multiple Benefits In Coronavirus Treatment, Says Glenmark Pharmaceuticals

Health Ministry Issues FAQs On Better Clinical Management Of COVID Patients In ICUs

Covid-19: Converge Biotech Launches Generic Favipiravir Tablet ‘VERGIFLU’ In India

Biophore India Gets DCGI Nod To Manufacture COVID Drug Favipiravir

COVID-19: Antiviral Drug Favipiravir Now Cheaper By 27 Per Cent

Delhi’s Lok Nayak Hospital Discontinues Use Of Favipiravir For COVID-19 Treatment

Lack Of Transparency In Subject Expert Committee Formed For Approval Of COVID-19 Drugs: AIDIAN

World Antimicrobial resistance (AMR) Awareness Week 2024

Cervical cancer elimination day of action

IIT Madras Study Reveals Oral Contraceptives Don’t Raise Blood Pressure in Female Athletes

Zilebesiran: Single Dose Shows Six-Month Blood Pressure Control in Hypertension Breakthrough

Fasting Enhances Glucose Regulation for Night Shift Employees: Study Finds

Parkinson’s Disease To Surge To 3.15 Million Worldwide By 2033: Warns Report

Experts Warn: Air Pollution Can Trigger Heart Attacks, Here’s How PM2.5 Can Cause Damage Arteries

Burning Eyes, Difficulty In Breathing: Toxic Delhi Smog And 500 AQI Levels Leave Residents Helpless